Alnylam Pharmaceuticals Inc
NASDAQ: ALNY
$244.89
-$1.91 (-0.8%)
Closing Price on November 22, 2024
ALNY Articles
The top analyst upgrades, downgrades and initiations seen from Friday, March 11, include Blackstone, Chevron, Diamond Offshore Drilling, Palo Alto Networks, Symantec and Total.
Published:
Last Updated:
Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.
Published:
Last Updated:
Alnylam Pharmaceuticals and The Medicines Company made waves Monday morning despite downward pressure from the broad markets.
Published:
Friday's top analyst upgrades, downgrades and initiations include Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel and Choice Hotels.
Published:
Wednesday's top analyst upgrades, downgrades and initiations includes Alcoa, Apache, Bob Evans, F5, Hain and McDonald's.
Published:
With volatility spiking much higher than last year, one thing that bodes well for equity investors is the number of insiders that continue to add to their holdings.
Published:
Thursday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls includes Alcatel-Lucent, ADM, Bank of America, Chesapeake Energy, Google, J.P. Morgan and MGM.
Published:
Friday's top analyst upgrades, downgrades and initiations include Citrix Systems, GoPro, Hewlett-Packard, Microsoft, Oracle and Teva Pharmaceutical.
Published:
For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams of revenue.
Published:
ThinkstockAfter being absolutely rocked back in the spring, the biotech sector has bounced back smartly. Even a bubble comment from the head of the Federal Reserve Janet Yellen didn’t stop the...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, June 11, 2013. They include Lululemon, Apple and Disney.
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Friday, May 24, 2013. They include Cubist Pharmaceuticals, Marvell Technology and Procter...
Published:
Last Updated:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated:
Stocks are down midday Monday, with the Dow Jones Industrial Average down 0.30%, the Nasdaq down 0.22% and the S&P 500 down 0.15%. Today’s big winners are two pharmaceutical companies, with...
Published:
Last Updated:
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech sector this week. ...
Published:
Last Updated: